QUOTE(Colin @ Mar 5 2008, 05:17 PM) [snapback]463818[/snapback]
I've run the gamut with nootropics and as far as choline sources or related compounds are concerned,I've used the following:
DMAE
centro
Alpha-GPC
choline b.
lecithin (20 grams ED)
Steve supplied me with one bottle of this and I am going to buy a second as an extension to make this a 60 day log,I figure I owe Steve a thorough log for being generous with the handful of complimentary supplements he included along with the PPC.I heart The Stevemeister,in a totally non-ghey way,I should add
Can I get three cheers for Steve-a-rooni?

...enough with the pedantic and thinly veiled latent homosexual undertones,I've digressed....
Well,I also think this compound holds a lot of promise not only WRT cognitive enhancement but as a means of favorably effecting body composition.I place its prime value as a highly effective defense against AAS induced liver toxicity.That said,after the first 30 day period is completed,I will be starting off on a 12 week AAS cycle with Masteron/Proviron for 10 weeks with test e during the final 4 weeks.I will have my liver values tested post cycle and will post results in this thread.
Nice comparison. PPC is a far better choline donor for the brain than DMAE, choline, and crappy lecithin. If you need anymore blood test forms let me know!
QUOTE
(PPC) 35 clinical investigations with 1,968 patients and 3 in 31 volunteers have also given clinical evidence of some positive effects in certain diseases, such as involutional dementias and multiple sclerosis. Improvements of subjective well-being, such as headache, dizziness, memory, concentration, endurance, irritability, insomnia, angina attacks, and walking time have been reported.
As adjuvant in acute and chronic hepatitis; cirrhosis; intoxications; fatty degeneration of the liver of any origin; functional cholestasis; prophylaxis of gallstone formation; radiation syndrome; pre-and postoperative care, especially in liver/gallbladder surgery.
Dyslipoproteinemia (hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia); atherosclerosis; coronary, cerebral, and peripheral circulatory disturbances; angina pectoris; condition following myocardial infarction, and apoplexy; hypertension due to sclerosis; vascular diseases, especially in diabetes mellitus; nephrotic syndrome; preoperative treatment for the prevention of thromboembolism.
Diabetes associated dyslipidemia that cannot be normalized completely by insulin or oral antidiabetics, particularly hypertriglyceridemia and hypoalpha-lipoproteinemia. Diabetes induced peripheral, coronary and cerebral disturbances of circulation.